Fractional Photothermolysis for the Treatment of Burn Scars
Recruitment status was Not yet recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The aim of our study is to determine the effect of fractional photothermolysis laser in the treatment of burn scars.
| Condition | Intervention | Phase |
|---|---|---|
|
Scar |
Procedure: Fractional laser treatment Procedure: Standard scar management |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Fractional Photothermolysis for the Treatment of Burn Scars |
- Evidence of improvement in color and texture of burn scars, using digital colorimeter and digital photography. [ Time Frame: 5 months ] [ Designated as safety issue: No ]
- Adverse effects: pain, erythema, edema, hypopigmentation, hyperpigmentation, hypertrophic scar and keloid formation [ Time Frame: 5 months ] [ Designated as safety issue: Yes ]
- Change in surface area and perimeter of burn scar [ Time Frame: 5 months ] [ Designated as safety issue: No ]
- Tissue pliability, elevation and flexibility with a digital piedemeter [ Time Frame: 5 months ] [ Designated as safety issue: No ]
- Change in collagen fiber organization and blood vessel density with a reflectance laser confocal microscope. [ Time Frame: 5 months ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 10 |
| Study Start Date: | November 2009 |
| Estimated Primary Completion Date: | April 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Laser treated scar
The standard treated scar arm consists of a similar lesion in an equivalent location in the same patient or the half of a lesion that is suitable to be divided (size at least 4% body surface area). This arm will be managed only with standard burn treatment modalities.
|
Procedure: Fractional laser treatment
A complete treatment will consist in four laser sessions with a second-generation erbium-doped 1,550-nm fractional photothermolysis laser (Fraxel SR laser, Reliant Technologies Inc at 1-month intervals. Treatment will be delivered with a 15-mm tip and concomitant air-cooling system (Zimmer MedizinSystems, Irvine, CA). Fluence and treatment level will be registered on every session and will be adjusted according to patient tolerance.
|
|
Active Comparator: Standard scar management
The standard scar management arm consists of a similar lesion in an equivalent location in the same patient or the half of a lesion that is suitable to be divided (size at least 4% body surface area). This arm will be managed only with standard burn treatment modalities.
|
Procedure: Standard scar management
The standard treated scar arm consists of a similar lesion in an equivalent location in the same patient or the half of a lesion that is suitable to be divided (size at least 4% body surface area). This arm will be managed only with standard burn treatment modalities.
|
Detailed Description:
One of the main problems in the management of burned patients is the treatment of post-burn scarring. Frequently this scars cover large areas, tend to retract, present pigmentary changes and are disfiguring, producing significant life quality impairment.
Unfortunately, there are very few therapeutic options for treating these scars, which can be secondary to reconstructive surgery or after spontaneous healing. In the last decades most reports in scar treatment have included, pressure garments, chemical peeling, dermabrasion, ablative and non-ablative laser therapy and surgery with varying degrees of success. There is only one report treating burn scars with fractional laser, with good results.
The aim of our study is to determine the effect of of a second-generation erbium-doped 1,550-nm fractional photothermolysis laser (Fraxel SR laser, Reliant Technologies Inc.) in the treatment of burn scars.
Eligibility| Ages Eligible for Study: | 6 Years to 16 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Burn scars should be located on the anterior thorax or abdomen with at least 4 months of evolution.
- The scar should be slightly elevated, with erythema and with no signs of keloid formation.
- Maximum scar dimension: 0.2 - 1% body surface area.
- Acceptance of informed consent for laser treatment.
Exclusion Criteria:
- Previous non-surgical treatment (i.e. dermabrasion, laser, peelings, bleaching agent. etc).
- Previous surgical treatment (i.e. graft)
Contacts and Locations| Contact: Rodrigo Schwartz, MD | 56-2-6108661 | schwartz.rodrigo@gmail.com |
| Chile | |
| Clinica Las Condes | Not yet recruiting |
| Santiago, RM, Chile | |
| Contact: Rodrigo J Schwartz, MD 56-2-6108661 | |
| Contact: Fresia Solias investigacion@coaniquem.cl | |
| Principal Investigator: Rodrigo J Schwartz, MD | |
| Sub-Investigator: Fresia Solis | |
| Sub-Investigator: Gonzalo Eguiguren, MD | |
| Sub-Investigator: Jorge Rojas, MD | |
| Sub-Investigator: pedro lobos, MD | |
| Sub-Investigator: Patricia Apt, MD | |
| Principal Investigator: | Rodrigo J Schwartz, MD | Clinica Las Condes |
More Information
Publications:
| Responsible Party: | Rodrigo Schwartz M.D., Clinica Las Condes |
| ClinicalTrials.gov Identifier: | NCT01005992 History of Changes |
| Other Study ID Numbers: | CLCCQFQ-1 |
| Study First Received: | October 30, 2009 |
| Last Updated: | October 30, 2009 |
| Health Authority: | Chile: Instituto de Salud Publica de Chile |
Keywords provided by Clinica las Condes, Chile:
|
Scars secondary to injuries to tissues caused by contact with physical (heat, electricity) o chemical agent. |
Additional relevant MeSH terms:
|
Cicatrix Fibrosis Pathologic Processes |
ClinicalTrials.gov processed this record on May 22, 2013